Signature 3 (BRCA signature), associated with inactivating BRCA1 or BRCA2 mutations in breast and pancreatic cancers and prevalent in ovarian cancer [35], is present in 27/39 samples. The gene discussed is BRCA2; the disease is ovarian carcinoma.